4 news items
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
ABBV
ATNM
AZN
19 Apr 24
expectations now leaning towards September—the environment remains ripe for biotech growth. Historical trends noted by Morgan Stanley suggest
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
ATNM
AZN
BMY
18 Apr 24
if interest rates trend downward, coupled with robust M&A activity and ongoing innovation. This environment is ripe for strategic investments
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
BMY
2 Apr 24
.
Sustaining Our Planet and Improving Health: Climate and Environment
- Prev
- 1
- Next